Aytu BioPharma, Inc. (AYTU) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -4.18M | 3.67M | -618K | 2.8M | -6.46M | 2.9M | -1.19M | -788K | -254K | -135K | -211K | 9.37M |
| Operating CF Margin % | -33.7% | 24.23% | -4.45% | 18.52% | -34.98% | 17.91% | -7.18% | -4.38% | -1.81% | -0.72% | -1.18% | 30.47% |
| Operating CF Growth % | 35.21% | 26.51% | 48.07% | 455.71% | -2441.34% | 2251.85% | -463.98% | -108.41% | 91.26% | 94.47% | 97.69% | 231.99% |
| Net Income | -5.62M | -10.58M | 1.97M | -19.88M | 3.99M | 788K | 1.47M | -4.62M | -2.89M | -220K | -8.12M | -2.46M |
| Depreciation & Amortization | 1.12M | 885K | 803K | 1.29M | 1.48M | 1.17M | 1.43M | 1.69M | 1.53M | 1.79M | 1.84M | 2.12M |
| Stock-Based Compensation | 0 | 283K | 114K | 0 | 139K | 151K | 173K | 242K | 699K | 707K | 725K | 900K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 2.13M | 9.11M | -3.48M | 19.75M | -2.31M | -2.44M | -3.41M | 3.47M | -16K | 1.27M | 6.69M | 6.35M |
| Working Capital Changes | -1.81M | 3.98M | -23K | 1.64M | -9.76M | 3.24M | -854K | -1.57M | 417K | -3.68M | -1.35M | 2.46M |
| Change in Receivables | 6.43M | 2.3M | -2.07M | 4.67M | -10.51M | -2.27M | 478K | 5.73M | 1.03M | 118K | -1.68M | 5.18M |
| Change in Inventory | 543K | 609K | 1.06M | -518K | -61K | 627K | 334K | -2.01M | -1.01M | -684K | -1.12M | -622K |
| Change in Payables | -1.04M | -1.08M | 1.74M | -1.44M | 398K | -1.81M | 3.14M | 0 | 852K | -4.01M | 946K | -1.34M |
| Cash from Investing | 0 | -17K | 0 | -3.02M | -69K | 145K | 381K | -34K | -45K | -174K | -76K | -155K |
| Capital Expenditures | 0 | -17K | 0 | -3.02M | -69K | -6K | -136K | -329K | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | 0.11% | - | 19.93% | 0.37% | 0.04% | 0.82% | 1.83% | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5K |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 151K | 517K | 295K | -45K | -174K | -76K | -150K |
| Cash from Financing | 872K | -6.26M | 2.3M | 12.99M | 4.3M | -2.76M | 911K | 1.07M | 530K | -126K | -2.73M | -5.4M |
| Debt Issued (Net) | 872K | -6.26M | 2.3M | -1.85M | 5.55M | -723K | 1.41M | -15.65M | 530K | -212K | -370K | -8.86M |
| Equity Issued (Net) | 0 | 0 | 0 | 14.84M | 0 | 0 | 0 | 0 | 0 | 86K | 0 | 2.56M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | -1.25M | -2.04M | -500K | 16.72M | 0 | 0 | -2.36M | 896K |
| Net Change in Cash | -3.31M | -2.6M | 1.68M | 12.78M | -2.23M | 290K | 102K | 246K | 231K | -435K | -3.02M | 3.81M |
| Free Cash Flow | -4.18M | 3.66M | -618K | 2.79M | -6.52M | 2.9M | -1.33M | -1.12M | -254K | -135K | -211K | 9.37M |
| FCF Margin % | -33.7% | 24.12% | -4.45% | 18.41% | -35.36% | 17.87% | -8% | -6.21% | -1.81% | -0.72% | -1.18% | 30.47% |
| FCF Growth % | 35.9% | 26.18% | 53.39% | 349.42% | -2468.5% | 2247.41% | -528.44% | -111.93% | 91.26% | 94.47% | 97.69% | 231.99% |
| FCF per Share | -0.40 | 0.36 | -0.03 | 0.41 | -0.80 | 0.34 | -0.15 | -0.20 | -0.05 | -0.02 | -0.04 | 2.31 |
| FCF Conversion (FCF/Net Income) | 0.74x | -0.35x | -0.31x | -0.14x | -1.62x | 3.69x | -0.81x | 0.17x | 0.09x | 0.61x | 0.03x | -3.81x |
| Interest Paid | 0 | 0 | 466K | 0 | 1.17M | 386K | 366K | 875K | 994K | 811K | 1.36M | 951K |
| Taxes Paid | 0 | 0 | 140K | 0 | 0 | 973K | 446K | 0 | 130K | 186K | 246K | 0 |